Annual EBITDA:
-$390.12M+$43.18M(+9.97%)Summary
- As of today, GH annual EBITDA is -$390.12 million, with the most recent change of +$43.18 million (+9.97%) on December 31, 2024.
- During the last 3 years, GH annual EBITDA has fallen by -$30.50 million (-8.48%).
- GH annual EBITDA is now -889.60% below its all-time high of -$39.42 million, reached on December 31, 2016.
Performance
GH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$96.41M+$4.39M(+4.36%)Summary
- As of today, GH quarterly EBITDA is -$96.41 million, with the most recent change of +$4.39 million (+4.36%) on June 30, 2025.
- Over the past year, GH quarterly EBITDA has dropped by -$6.50 million (-7.22%).
- GH quarterly EBITDA is now -695.62% below its all-time high of -$12.12 million, reached on March 31, 2018.
Performance
GH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$419.46M-$6.50M(-1.57%)Summary
- As of today, GH TTM EBITDA is -$419.46 million, with the most recent change of -$6.50 million (-1.57%) on June 30, 2025.
- Over the past year, GH TTM EBITDA has increased by +$47.75 million (+10.22%).
- GH TTM EBITDA is now -1456.54% below its all-time high of -$26.95 million, reached on September 30, 2017.
Performance
GH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +10.0% | -7.2% | +10.2% |
| 3Y3 Years | -8.5% | +20.5% | +2.2% |
| 5Y5 Years | -582.9% | -97.1% | -162.9% |
GH EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -8.5% | +36.6% | -8.4% | +48.3% | -4.6% | +19.3% |
| 5Y | 5-Year | -582.9% | +36.6% | -37.9% | +48.3% | -162.9% | +19.3% |
| All-Time | All-Time | -889.6% | +36.6% | -695.6% | +48.3% | -1456.5% | +19.3% |
GH EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$96.41M(+4.4%) | -$419.46M(-1.6%) |
| Mar 2025 | - | -$100.81M(+12.7%) | -$412.96M(-3.0%) |
| Dec 2024 | -$390.12M(+10.0%) | -$115.51M(-8.2%) | -$401.13M(+15.0%) |
| Sep 2024 | - | -$106.73M(-18.7%) | -$471.93M(-1.0%) |
| Jun 2024 | - | -$89.92M(-1.1%) | -$467.21M(+3.8%) |
| Mar 2024 | - | -$88.97M(+52.2%) | -$485.77M(+6.6%) |
| Dec 2023 | -$433.31M(+29.5%) | -$186.31M(-82.6%) | -$519.91M(-11.4%) |
| Sep 2023 | - | -$102.01M(+6.0%) | -$466.86M(+6.5%) |
| Jun 2023 | - | -$108.48M(+11.9%) | -$499.25M(+2.5%) |
| Mar 2023 | - | -$123.11M(+7.6%) | -$512.10M(-1.8%) |
| Dec 2022 | -$614.91M(-71.0%) | -$133.26M(+0.8%) | -$503.03M(-9.0%) |
| Sep 2022 | - | -$134.39M(-10.8%) | -$461.35M(-7.6%) |
| Jun 2022 | - | -$121.34M(-6.4%) | -$428.74M(-7.3%) |
| Mar 2022 | - | -$114.04M(-24.5%) | -$399.45M(-2.9%) |
| Dec 2021 | -$359.62M | -$91.58M(+10.0%) | -$388.27M(-1.3%) |
| Sep 2021 | - | -$101.79M(-10.6%) | -$383.25M(-9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$92.04M(+10.5%) | -$351.36M(-14.0%) |
| Mar 2021 | - | -$102.85M(-18.8%) | -$308.24M(-36.5%) |
| Dec 2020 | -$225.07M(-294.0%) | -$86.56M(-23.8%) | -$225.80M(-41.5%) |
| Sep 2020 | - | -$69.90M(-42.9%) | -$159.55M(-53.2%) |
| Jun 2020 | - | -$48.92M(-139.7%) | -$104.18M(-53.5%) |
| Mar 2020 | - | -$20.41M(-0.5%) | -$67.86M(+1.3%) |
| Dec 2019 | -$57.13M(+24.7%) | -$20.32M(-39.9%) | -$68.76M(+6.7%) |
| Sep 2019 | - | -$14.53M(-15.2%) | -$73.66M(+9.4%) |
| Jun 2019 | - | -$12.61M(+40.8%) | -$81.34M(+8.1%) |
| Mar 2019 | - | -$21.31M(+15.5%) | -$88.48M(-11.6%) |
| Dec 2018 | -$75.84M(-0.7%) | -$25.22M(-13.6%) | -$79.29M(-17.6%) |
| Sep 2018 | - | -$22.20M(-12.4%) | -$67.43M(+6.6%) |
| Jun 2018 | - | -$19.75M(-63.0%) | -$72.17M(-37.7%) |
| Mar 2018 | - | -$12.12M(+9.3%) | -$52.42M(-30.1%) |
| Dec 2017 | -$75.31M(-91.0%) | -$13.36M(+50.4%) | -$40.30M(-49.6%) |
| Sep 2017 | - | -$26.95M | -$26.95M |
| Dec 2016 | -$39.42M | - | - |
FAQ
- What is Guardant Health, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Guardant Health, Inc.?
- What is Guardant Health, Inc. annual EBITDA year-on-year change?
- What is Guardant Health, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Guardant Health, Inc.?
- What is Guardant Health, Inc. quarterly EBITDA year-on-year change?
- What is Guardant Health, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Guardant Health, Inc.?
- What is Guardant Health, Inc. TTM EBITDA year-on-year change?
What is Guardant Health, Inc. annual EBITDA?
The current annual EBITDA of GH is -$390.12M
What is the all-time high annual EBITDA for Guardant Health, Inc.?
Guardant Health, Inc. all-time high annual EBITDA is -$39.42M
What is Guardant Health, Inc. annual EBITDA year-on-year change?
Over the past year, GH annual EBITDA has changed by +$43.18M (+9.97%)
What is Guardant Health, Inc. quarterly EBITDA?
The current quarterly EBITDA of GH is -$96.41M
What is the all-time high quarterly EBITDA for Guardant Health, Inc.?
Guardant Health, Inc. all-time high quarterly EBITDA is -$12.12M
What is Guardant Health, Inc. quarterly EBITDA year-on-year change?
Over the past year, GH quarterly EBITDA has changed by -$6.50M (-7.22%)
What is Guardant Health, Inc. TTM EBITDA?
The current TTM EBITDA of GH is -$419.46M
What is the all-time high TTM EBITDA for Guardant Health, Inc.?
Guardant Health, Inc. all-time high TTM EBITDA is -$26.95M
What is Guardant Health, Inc. TTM EBITDA year-on-year change?
Over the past year, GH TTM EBITDA has changed by +$47.75M (+10.22%)